Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
NCT05922839
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Warm Autoimmune Hemolytic Anemia
Interventions
DRUG:
Zanubrutinib
Sponsor
Chen Miao